Skip to main content
OpenTrials
Completed

NCT Number: NCT00597337

Effectiveness of the FearNot!v.2.0 Software in Reducing Bullying Victimisation Among Primary School Children

This study will evaluate the effectiveness of a virtual learning treatment in reducing bullying among primary school children in the UK and Germany.

Completed

Looking for future studies?

Notify Me

Key information

Age range

8 year–11 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Warwick

Coventry, CV4 7AL, United Kingdom

About this study

In this study, a virtual learning environment application called FearNot!v.2.0 will be evaluated as a way to improve the quality of life in schools by altering children's attitudes and behavior towards bullying.

Participants will be assigned to either the intervention or the control group. The intention was to assign randomly, however, only a minority of primary schools have the computer facilities to run the software with all pupils participating. Thus, assignment is based on the school computer compatibility with the FearNot!v.2.0 software for intervention versus control group controlling for social variables. Participants in the intervention group will interact with the software during 30-minute sessions once a week for a total of 3 weeks while participants in the control group will follow the normal curriculum.

The FearNot! narrative comprises a number of emergent episodes, which play out like an improvisational drama. During each of these emergent episodes, the characters will act out their roles resulting in a dramatic movie-like display on the computer's monitor. In between each of these episodes, the child can interact with the victim character. He/she can learn how the character feels, and offer them coping strategy advice as to how to behave in the following episode.

Outcomes will be assessed through student questionnaires at baseline, one week, and four weeks after treatment. In addition, classroom teachers will be asked to complete the Teacher Incidence of Bullying Scale at baseline and 4 weeks after the treatment.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

for schools:

  • Mixed
  • Not currently involved in intervention studies specific to countering bullying
  • Access to computers that are compatible to run FearNot!v.2.0 (for intervention schools)

Inclusion criteria

for participants:

  • Age between 8-11
  • Passive parental consent

Exclusion criteria

  • Enrolled in special education schools

Treatment and study plan

FearNot

Behavioral

Behavioral: Three sessions of FearNot!v.2.0 software interaction over a three-week period (each session lasting approximately 30 minutes)

Primary outcomes

  1. Bullying victimisation - Participant Roles Questionnaire

    Time frame: Measured 1 week post-treatment and at 4 week follow-up

Secondary outcomes

  1. Knowledge about Bullying and Coping Strategies Knowledge Questionnaire

    Time frame: Measured 1-week post-treatment and at 4-week follow-up

  2. Peer nominations of defenders

    Time frame: Measured 1 week post-treatment and at 4 week follow-up

  3. Hymel, Rocke & Bonanno Moral Disengagement Questionnaire

    Time frame: Measured 1 week post-treatment and at 4 week follow-up

  4. Janke and Janke Adjective Word List (adapted)

    Time frame: Measured after each treatment session

Sponsors and collaborators

Lead sponsor

University of Warwick

Other

Collaborators

  • European Commission
  • University of Bamberg
  • University of Hertfordshire
  • University of Wuerzburg

Registry information

Official study title

Using a Virtual Learning Environment to Reduce Bullying: Evaluation of the FearNot!v.2.0 Intervention in Primary Schools in England and Germany

Important dates

Study start
2007
Primary completion
2008
Study completion
2008
First posted
Jan 18, 2008
Registry last updated
Dec 18, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.